+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07362082

Randomized Trial of the RecoveryPad Telehealth Platform Compared to Usual Treatment for Adults with Moderate or Severe Opioid Use Disorder

Led by Yale University · Updated on 2026-09-21

470

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a telehealth platform called RecoveryPad to support adults with moderate or severe opioid use disorder in this randomized clinical trial. The study aims to compare the effects of using RecoveryPad against usual treatment practices including referrals to harm reduction and community resources. The trial is sponsored by Yale University and focuses on treatment engagement and attendance. Participants will be randomly assigned to either use the RecoveryPad telehealth platform, which is designed to enhance motivation and engagement in treatment for opioid use disorder, or receive treatment as usual without the telehealth device. The study will track participant progress for up to 90 days, focusing on attendance and engagement with medication for opioid use disorder MOUD as well as overdose events. During the study, participants will be monitored through attendance records for MOUD at 30 and 90 days, engagement with treatment, and any overdose events. The study requires participants to have access to a smartphone, tablet, or computer with internet and text capabilities, and they must be able to communicate in English. The trial is expected to run from September 2026 to December 2027, with primary outcome data collected by October 2027.

CONDITIONS

Brief Title

A Clinical Trial of Telehealth Treatment for Opioid Use Disorders

Research Team

R

Rebekah Heckmann, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here